Interleukin-17 (IL-17)-induced MicroRNA 873 (miR-873) Contributes to the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting A20 Ubiquitin-editing Enzyme-Reference-Cited by-同舟云学术

Interleukin-17 (IL-17)-induced MicroRNA 873 (miR-873) Contributes to the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting A20 Ubiquitin-editing Enzyme

Published:2014-10 Issue:42 Volume:289 Page:28971-28986
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Liu Xiaomei,He Fengxia,Pang Rongrong,Zhao Dan,Qiu Wen,Shan Kai,Zhang Jing,Lu Yanlai,Li Yan,Wang Yingwei

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference47 articles.

1. Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis;Creeke;Ther. Adv. Neurol. Disord,2013

2. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration;Hauser;Neuron,2006

3. T(H)-17 cells in the circle of immunity and autoimmunity;Bettelli;Nat. Immunol,2007

4. IL-17 and Th17 Cells;Korn;Annu. Rev. Immunol,2009

5. TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic?;Marwaha;Front. Immunol,2012

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isoliquiritigenin alleviates experimental autoimmune encephalomyelitis by modulating inflammatory and neuroprotective reactive astrocytes;Biomedicine & Pharmacotherapy;2024-09

2. MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review;Frontiers in Molecular Neuroscience;2024-05-31

3. Experimental capture of miRNA targetomes: disease-specific 3′UTR library-based miRNA targetomics for Parkinson’s disease;Experimental & Molecular Medicine;2024-04-01

4. Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases;Journal of Clinical Medicine;2023-12-27

5. MicroRNAs and their Implications in CD4+ T-cells, Oligodendrocytes and Dendritic Cells in Multiple Sclerosis Pathogenesis;Current Molecular Medicine;2023-08